Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | BFST | MCB |
|---|---|---|
| Price | $30.44 | $87.05 |
| Change today | ▼ 0.98% | ▼ 1.89% |
| Market cap | $990.82M | $1.08B |
| Return, 3 months | +1.7% | -10.7% |
| Return, year to date | +18.3% | +15.0% |
| Return, 1 year | +31.8% | +16.6% |
| P/E (TTM) | 10.8 | 11.1 |
| P/B | 1.1 | 1.1 |
| P/E percentile vs own 5y | 84th | 58th |
| Dividend yield | 1.94% | 0.86% |
| Revenue growth (YoY, latest qtr) | +16.5% | +21.9% |
| Net profit growth (YoY) | +9.4% | +2.4% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | 25.5% | 24.8% |
| Return on equity | 10.2% | 10.2% |
| Analyst target vs. price | +18.3% | +20.6% |
| Analyst buy share | 100% | 50% |
| RSI (14) | 43 | 39 |
| 30-day volatility | 14.4% | 17.0% |
| Max drawdown, 1 year | -13.5% | -18.7% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
